PHARMACIE BOBILLOT MONTSOURIS : revenue, balance sheet and financial ratios

PHARMACIE BOBILLOT MONTSOURIS is a French company founded 19 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75013), this company of category PME shows in 2018 a revenue of 2.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE BOBILLOT MONTSOURIS (SIREN 490493384)
Indicator 2024 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C 1 986 422 € 1 964 388 € 1 950 155 €
Net income 85 097 € 195 922 € 240 501 € 138 304 € 102 887 € 139 809 € 162 404 € 153 886 €
EBITDA N/C N/C N/C N/C N/C 188 931 € 231 948 € 225 948 €
Net margin N/C N/C N/C N/C N/C 7.0% 8.3% 7.9%

Revenue and income statement

In 2024, PHARMACIE BOBILLOT MONTSOURIS generates positive net income of 85 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 154 k€ -> 85 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

85 097 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 89%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.287%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

89.287%

Solvency indicators evolution
PHARMACIE BOBILLOT MONTSOURIS

Sector positioning

Debt ratio
0.29 2024
2021
2022
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of PHARMACIE BOBILLOT MONTSO... (0.29) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
89.29% 2024
2021
2022
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent +14 pts over 3 years

In 2024, the financial autonomy of PHARMACIE BOBILLOT MONTSO... (89.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE BOBILLOT MONTSOURIS

Positioning of PHARMACIE BOBILLOT MONTSOURIS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE BOBILLOT MONTSOURIS is estimated at 1 188 017 € (range 827 316€ - 1 777 341€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
827k€ 1188k€ 1777k€
1 188 017 € Range: 827 316€ - 1 777 341€
NAF 5 année 2024

Valuation method used

Net Income Multiple
85 097 € × 14.0x = 1 188 017 €
Range: 827 316€ - 1 777 341€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE BOBILLOT MONTSOURIS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE BOBILLOT MONTSOURIS

What is the revenue of PHARMACIE BOBILLOT MONTSOURIS ?

The revenue of PHARMACIE BOBILLOT MONTSOURIS in 2018 is 2.0 M€.

Is PHARMACIE BOBILLOT MONTSOURIS profitable?

Yes, PHARMACIE BOBILLOT MONTSOURIS generated a net profit of 85 k€ in 2024.

Where is the headquarters of PHARMACIE BOBILLOT MONTSOURIS ?

The headquarters of PHARMACIE BOBILLOT MONTSOURIS is located in PARIS (75013), in the department Paris.

Where to find the tax return of PHARMACIE BOBILLOT MONTSOURIS ?

The tax return of PHARMACIE BOBILLOT MONTSOURIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE BOBILLOT MONTSOURIS operate?

PHARMACIE BOBILLOT MONTSOURIS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.